Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

The Most Important Detail Investors Missed in Take-Two's Earnings Report
The Most Important Detail Investors Missed in Take-Two's Earnings Report

Leading game companies reported a significant increase in engagement during the most recent quarter with people staying home amid the COVID-19 pandemic. Take-Two Interactive (NASDAQ: TTWO) called

Where Will Procter & Gamble Be in 5 Years?
Where Will Procter & Gamble Be in 5 Years?

It's the owner of some of the most recognizable consumer brand names in the world. Procter & Gamble (NYSE: PG) is the parent to Tide laundry detergent, Gillette razors, and Luvs diapers, just to

5 High-Yield Dividend Stocks to Watch
5 High-Yield Dividend Stocks to Watch

High dividend yields help investors generate income from their investments beyond just capital appreciation -- but not all stocks are created equal. Sometimes high yields indicate that a business is

3 Recession-Proof Stocks to Buy Now
3 Recession-Proof Stocks to Buy Now

The COVID-19 pandemic stoked deep fears about how the economy would cope with the shutdowns required to get the disease under control. Consequently, stocks sold off in February and March as job

Take Zoom’s Amazing Free Cash Flow With a Grain of Salt
Take Zoom’s Amazing Free Cash Flow With a Grain of Salt

Few companies have benefited from the pandemic-driven lockdowns around the world more than Zoom Video Communications (NASDAQ: ZM). Employers have turned to Zoom's video conferencing tech as working

The Overlooked Way Coronavirus Relief Hurts Social Security
The Overlooked Way Coronavirus Relief Hurts Social Security

For Social Security beneficiaries, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) is best known for the COVID-19 stimulus money it provided. But the CARES Act did more than just

The 4 Likeliest States to Legalize Marijuana in November
The 4 Likeliest States to Legalize Marijuana in November

Despite its numerous growing pains over the past year and change, marijuana remains one of the fastest expanding industries on the planet. After logging $10.9 billion in legal worldwide sales in

3 Smartest Stocks to Buy Right Now
3 Smartest Stocks to Buy Right Now

I'll admit right out of the gate that any list of the smartest stocks to buy will be debatable. After all, the smartest stocks for a person in their thirties are likely to be very different than the

3 Ways COVID-19 Could Put Your Retirement at Risk
3 Ways COVID-19 Could Put Your Retirement at Risk

Saving for retirement is challenging enough as it is, but the coronavirus pandemic is making it even harder for many Americans. The stock market took a nosedive during the first quarter of 2020, and

3 Things to Watch in the Stock Market This Week
3 Things to Watch in the Stock Market This Week

Stocks rallied last week on hopes that the U.S. economy might emerge from the COVID-19 pandemic slump just as quickly as it had entered it. Both the Dow Jones Industrial Average (DJINDICES: ^DJI)

Done With Taxes in 2020? 4 Steps to Make Next Year's Easier
Done With Taxes in 2020? 4 Steps to Make Next Year's Easier

Because of COVID-19, the 2019 tax filing deadline hasn't yet arrived. But if you're ahead of schedule and have already finished up last year's returns, it's time to start thinking ahead to next

7 Ways to Invest to Support Racial Justice
7 Ways to Invest to Support Racial Justice

Money isn't everything. If you're a socially conscious investor, it isn't all about bottom-line earnings or a company's recent sales growth. Those things are nice to have, but many investors --

Why Match Group Stock Climbed 15.7% Last Month
Why Match Group Stock Climbed 15.7% Last Month

Shares of Match Group (NASDAQ: MTCH) gained 15.7% in May, according to data from S&P Global Market Intelligence. The stock saw big swings as investors digested the company's quarterly results early

Are We Actually in a Recession? It's Complicated.
Are We Actually in a Recession? It's Complicated.

The economic picture in the U.S. has been pretty bleak since mid-March, when COVID-19 cases started multiplying rapidly. Though unemployment levels fell in May compared to April's number, the

Worried Another Stock Market Crash Is Coming? 3 Things You Should Do Right Now
Worried Another Stock Market Crash Is Coming? 3 Things You Should Do Right Now

You're not alone if you think another stock market crash is on the way. Over half of CFOs expect the Dow Jones Industrial Average will plunge as low as it did in the March market sell-off, according

Is Moderna Really the Leader in the COVID-19 Vaccine Race?
Is Moderna Really the Leader in the COVID-19 Vaccine Race?

When Dr. Anthony Fauci speaks, people listen. The director of the National Institute of Allergy and Infectious Diseases (NIAID) quickly became a top spokesperson for the U.S. effort to fight the

3 Investing Tricks to Double Your Money
3 Investing Tricks to Double Your Money

Want to double your money? There's no shortage of suggestions for how to do that out there. Some will urge you to gamble, invest with borrowed money, chase high-flying stocks, try to time the

These Are Americans' Top 3 Retirement Concerns
These Are Americans' Top 3 Retirement Concerns

Retirement conjures as many worrisome thoughts as it does exciting ones, largely because it's such a big expense. It's not unreasonable to think you could need $1 million or more, and some people

3 High-Yield Dividend Stocks That Are Still Bargains
3 High-Yield Dividend Stocks That Are Still Bargains

The stock market rebound has resulted in two things happening that aren't great for income investors. Dividend yields have gone down for many stocks. And valuations aren't nearly as attractive as

Could Gilead's COVID-19 Drug Make $7 Billion Per Year?
Could Gilead's COVID-19 Drug Make $7 Billion Per Year?

SVB Leerink analyst Geoffrey Porges has changed his mind about Gilead Sciences' (NASDAQ: GILD) COVID-19 drug, remdesivir. Less than six weeks ago, he wrote to clients that remdesivir had "limited

5 Pot Stocks That Posted Profits in Their Most Recent Earnings
5 Pot Stocks That Posted Profits in Their Most Recent Earnings

Many investors come to expect losses from cannabis companies. After all, the industry's still in its early stages and it's undergoing a lot of growing pains. But that doesn't mean investors have to

How to Prepare Financially for a Second Wave of COVID-19
How to Prepare Financially for a Second Wave of COVID-19

As more and more states beGIN to ease restrictions and open back up, health experts warn of a resurgence of COVID-19 cases -- a so-called second wave. Whether that wave comes during the summer, in

3 Top Small-Cap Stocks to Buy Right Now
3 Top Small-Cap Stocks to Buy Right Now

The market's rise in recent weeks seems a bit disconnected from reality, given high unemployment, unknowns about the future of the COVID-19 pandemic, and the uncertainty of an upcoming election

Better Buy: AbbVie vs. Johnson & Johnson
Better Buy: AbbVie vs. Johnson & Johnson

AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) are stalwart companies that are in a lot of investors' portfolios. Analysts almost always preach diversification, and these two healthcare

Social Security's Judgment Day May Be Only 12 Years Away
Social Security's Judgment Day May Be Only 12 Years Away

It's time for 64 million current beneficiaries, and the tens of millions of future beneficiaries, to face one key reality: Social Security is in some very real trouble.

Since 1985, the annually